13 events about "nuevo nordisk"

25 May 2026, 15:22

The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.

Sources

International

18 February 2026, 08:17

The European Commission has approved the 7.2 mg dose of the medication Wegovy, which can support a more pronounced weight loss.

Sources

International

4 February 2026, 12:22

Novo Nordisk's earnings fell by 20% following warnings about price pressures in 2026

Sources

International

24 December 2025, 07:25

Novo Nordisk's shares rose by 9.2% after the Danish company became the first to receive FDA approval for the GLP-1 pill Wegovy, intended for weight loss.

Sources

International

23 December 2025, 08:52

The U.S. Food and Drug Administration (FDA) has approved the weight loss pill Wegovy, developed by Novo Nordisk.

Sources

+4

Health

25 November 2025, 04:46

Novo Nordisk has announced that the study for semaglutide in the treatment of Alzheimer did not meet its objectives, causing a 10% drop in shares.

Sources

Economy

15 November 2025, 04:32

European stocks closed lower on Friday, affected by fears of a speculative bubble in AI and the weakness of the global economy.

Sources

Economy

9 November 2025, 06:25

Pfizer won the auction for the acquisition of Metsera, with a bid of 10 billion dollars, thus ending the competition with Novo Nordisk.

Sources

International

4 November 2025, 06:17

Pfizer has sued Novo Nordisk, accusing it of anti-competitive practices in an attempt to take over Metsera, a potential competitor in the obesity treatment market.

Sources

Health

22 October 2025, 05:51

Crisis at the peak of Novo Nordisk, at one point the most valuable European company. The president and several independent directors resign after a conflict with the majority shareholder.

Sources

International

10 September 2025, 09:28

The pharmaceutical giant Novo Nordisk announced the availability of 9,000 employees, equivalent to 11.5% of its workforce.

Sources

+2

International

30 July 2025, 07:57

Novo Nordisk has appointed a new CEO, Maziar Mike Doustdar, and revised its financial estimates for 2023, forecasting a decline in sales.

Sources

Economy

16 October 2024, 09:14

The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge